LONDON, July 19, 2018 /PRNewswire/ -- Neurovascular Intervention devices are used treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula, etc.
Download the full report: https://www.reportbuyer.com/product/5476600
According to IQ4I analysis, the Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR to reach $4,473.2
million by 2024. The increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, acquisitions and favourable reimbursements are increasing the use of artificial embolization devices, stents, thromobectomy devices and support devices which include microcatheters, embolic protection system and others as an efficient way for treating the neurovascular diseases.Neurovascular Intervention devices global market is segmented on the basis of products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. The artificial embolization devices segment accounted the largest share in 2017 and is projected to grow at mid single digit CAGR from 2017 to 2024 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation. The artificial embolization devices are sub-segment into coils, liquid embolics, flow diverter and flow disruptor. The coil segment accounted the largest share in 2017 due to development of softest coils and more number of companies producing bare metal coils over coated coils due to its advantages. The liquid embolics segment is fastest growing segment and is projected to grow at a strong CAGR of 8.7% from 2017 to 2024 due to its advantages like presence of effective embolic materials which penetrates small vessels, cohesiveness and non-adherence when compared to glues. The coils are further classified into bare metal coils and coated coils. The bare metal coil segment accounted for the largest share in 2017 and fastest growing segment and is projected to grow at a CAGR of 6.4% from 2017 to 2024 due to increased compatibility, efficacy and cost efficient. The Stents are sub-segmented into intracranial stents and carotid stents. The carotid stents segment accounted the largest share of 74.2% and fastest growing segment in 2017 due to development of self expanding stents. The intracranial stents are sub-segmented into stenosis stent, aneurysm coil stent, neck reconstruction stent and stent graft. The aneurysm coil stents segment accounted the largest share in 2017 and fastest growing segment during forecasting period due to increase intracranial aneurysm procedures. The thrombectomy devices are sub-segmented into stent retrievers and aspiration devices. The stent retriever segment accounted the largest share of 76.3% and fastest growing segment from 2017 to 2024 due to product approvals and expansion in indication of treatment from 6 hrs to 24 hrs. The Support devices are sub-segmented into microcatheters, embolic protection system and others. The microcatheter segment accounted the largest share in 2017.The applications are segmented into intracranial aneurysm, ischemic stroke, arteriovenous malformation and carotid stenosis & others. Among application, intracranial aneurysm segment accounted for the largest share in 2017 due to the increase in incidence and prevalence of intracranial aneurysm and increase in aging population. The Ischemic stroke segment is fastest growing segment during forecasting period due to increase in product regulatory approvals of thrombectomy devices, increase in ischemic stroke patients and procedures, technological advancement in stent retriever and aspiration devices.Geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounts for the highest market share followed by Europe. Favourable reimbursement coverage and increase in incidence and prevalence of neurovascular diseases are the driving factors of Neurovascular Intervention devices market. However, Asian countries especially India and China are the fastest growing nations at strong CAGR of 11.4% from 2017 to 2024 with its growing demand for neurovascular intervention device due to increase in aging population and decreasing the cost of neurovascular products.The Neurovascular Intervention devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Neurovascular Intervention device are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Terumo Corporation (Japan), Balt Extrusion (Blockade Medical, LLC) (France), Penumbra, Inc. (U.S.), Johnson & Johnson (U.S.), Acandis GmbH (Germany), Microport Scientific Corporation (China), Phenox GmbH (Germany), Penumbra Inc (U.S.), Abbott Laboratories (U.S.), InspireMD (Israel), Boston Scientific Corporation (U.S.) and Cardinal Health (Cordis Corporation) (U.S.).The report provides an in-depth market analysis of the above-mentioned segments across the following regions:• North América• U.S.• Others• Europe• Germany• U.K.• France• Others• Asia-Pacific• Japan• China• India• Others• Rest of the World (RoW)• Brazil• Rest of Latin America• Middle East & OthersDownload the full report: https://www.reportbuyer.com/product/5476600
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: firstname.lastname@example.org
Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-neurovascular-intervention-devices-global-market-is-expected-to-grow-at-a-high-single-digit-cagr-to-reach-4-473-2-million-by-2024--300683751.html